Zhang, Hanxu
Zhang, Zhuo
Liu, Zhiyan
Mu, Guangyan
Xie, Qiufen
Zhou, Shuang
Wang, Zhe
Cao, Yu
Tan, Yunlong
Wei, Xiaohua
Yuan, Dongdong
Xiang, Qian
Cui, Yimin
Funding for this research was provided by:
National Science and Technology Major Projects for “Major New Drugs Innovation and Development” of China (No. 2017ZX09304028)
National Natural Science Foundation of China (No. 81973395, No. 81872940)
National Key Research and Development Program of China (No. 2016YFC0904900)
Article History
Received: 27 March 2022
Accepted: 15 December 2022
First Online: 28 December 2022
Declarations
:
: The protocol was approved by an independent ethics committee and the Institutional Review Board of Peking University First Hospital and all participating research subcentral hospitals. The trial registration number is NCT03161496. All subjects were enrolled in this study after signing informed consent.
: All authors of this paper consent for publishing the manuscript and figures in the journal.
: The authors declare that they have no competing interests.